We are live on ! Find out more
TBPH icon

Theravance Biopharma
TBPH

108 hedge funds and large institutions have $1.16B invested in Theravance Biopharma in 2019 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 33 increasing their positions, 28 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

263% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 8

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

29% more capital invested

Capital invested by funds: $900M → $1.16B (+$260M)

18% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 28

17% more funds holding

Funds holding: 92 → 108 (+16)

2.59% less ownership

Funds ownership: 81.55% → 78.97% (-2.6%)

45% less call options, than puts

Call options by funds: $726K | Put options by funds: $1.33M

Holders
108
Holders Change
+16
Holders Change %
+17.39%
% of All Funds
2.13%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.06%
New
29
Increased
33
Reduced
28
Closed
8
Calls
$726K
Puts
$1.33M
Net Calls
-$605K
Net Calls Change
-$1.65M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$61.8M
2
C
Chescapmanager
Maryland
+$6.83M
3
RCMNY
Rubric Capital Management (New York)
New York
+$3.37M
4
Norges Bank
Norges Bank
Norway
+$2.33M
5
NM
Newtyn Management
New York
+$2.13M

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$3.84M
2
3C
361 Capital
Colorado
-$2.52M
3
Ameriprise
Ameriprise
Minnesota
-$1.34M
4
Squarepoint
Squarepoint
New York
-$967K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$722K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
26
Tekla Capital Management
Massachusetts
$3.05M +$1.39M +71,624 +155%
Goldman Sachs
27
Goldman Sachs
New York
$3.02M -$32.7K -1,681 -1%
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$2.6M +$363K +18,656 +23%
Millennium Management
29
Millennium Management
New York
$2.6M +$1.95M +100,551 New
RA
30
Royce & Associates
New York
$2.42M – – –
Swiss National Bank
31
Swiss National Bank
Switzerland
$2.11M +$44.7K +2,300 +3%
LCM
32
Laurion Capital Management
New York
$2.01M +$1.51M +77,528 New
CEP
33
Chicago Equity Partners
Illinois
$1.83M -$221K -11,375 -14%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$1.78M – – –
State of Wisconsin Investment Board
35
State of Wisconsin Investment Board
Wisconsin
$1.72M – – –
AllianceBernstein
36
AllianceBernstein
Tennessee
$1.66M +$25.3K +1,300 +2%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$1.5M +$22.2K +1,141 +2%
Barclays
38
Barclays
United Kingdom
$1.42M +$187K +9,628 +21%
First Trust Advisors
39
First Trust Advisors
Illinois
$1.31M +$985K +50,692 New
CAM
40
Cormorant Asset Management
Massachusetts
$1.29M +$972K +50,000 New
MCM
41
Moore Capital Management
New York
$1.29M +$972K +50,000 New
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$1.09M -$115K -5,900 -12%
Deutsche Bank
43
Deutsche Bank
Germany
$1.07M +$554K +28,519 +221%
NSEDCP
44
NJ State Employees Deferred Compensation Plan
New Jersey
$988K – – –
EGM
45
Engineers Gate Manager
New York
$925K +$153K +7,891 +28%
UBS AM
46
UBS AM
Illinois
$874K +$135K +6,932 +26%
PPA
47
Parametric Portfolio Associates
Washington
$815K -$468K -24,097 -43%
VEA
48
Virtus ETF Advisers
New York
$756K -$276K -14,226 -33%
Voloridge Investment Management
49
Voloridge Investment Management
Florida
$753K +$566K +29,102 New
State Board of Administration of Florida Retirement System
50
State Board of Administration of Florida Retirement System
Florida
$737K -$4.66K -240 -0.8%
1
2
3 4 5

TBPH Hedge Fund Activity: Q4 2019 in Review

108 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Theravance Biopharma (TBPH) for Q4 2019, worth a combined $1.16B — up 29% from $900M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new TBPH positions and 8 closed out — a net gain of 21 holders — while 33 added to existing stakes and 28 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $61.8M. The largest seller was UBS Group, cutting an estimated $3.84M.

  • 108 institutional investors held Theravance Biopharma (TBPH) as of Q4 2019, up from 92 in Q3 2019.
  • Funds reported $1.16B of Theravance Biopharma stock for Q4 2019, up 29% quarter-over-quarter.
  • 29 funds opened new Theravance Biopharma positions in Q4 2019 and 8 closed out, a net change of +21 holders.
  • The largest Theravance Biopharma buyer in Q4 2019 was Wellington Management Group, an estimated $61.8M added.
  • The largest Theravance Biopharma seller in Q4 2019 was UBS Group, an estimated $3.84M sold.

Based on aggregated 13F filings for Q4 2019.